Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • krobison
    Senior Member
    • Nov 2007
    • 734

    #1

    Biases in Illumina transcriptome sequencing

    Would be interesting to see similar studies on other platforms; if it is really a hexamer priming issue, should be platform-independent.

    http://nar.oxfordjournals.org/cgi/content/full/gkq224v1

    Biases in Illumina transcriptome sequencing caused by random hexamer priming
    Kasper D. Hansen1,*, Steven E. Brenner2 and Sandrine Dudoit1,3
    1Division of Biostatistics, School of Public Health, UC Berkeley, 101 Haviland Hall, Berkeley, CA 94720-7358, 2Department of Plant and Microbial Biology, UC Berkeley, 461 Koshland Hall, Berkeley, CA 94720-3102 and 3Department of Statistics, UC Berkeley, 367 Evans Hall, Berkeley, CA 94720-3860, USA

    *To whom correspondence should be addressed. Tel: +1 510 642 3241; Fax: +1 510 643 5163; Email: [email protected]

    Received December 1, 2009. Revised March 16, 2010. Accepted March 17, 2010.

    Generation of cDNA using random hexamer priming induces biases in the nucleotide composition at the beginning of transcriptome sequencing reads from the Illumina Genome Analyzer. The bias is independent of organism and laboratory and impacts the uniformity of the reads along the transcriptome. We provide a read count reweighting scheme, based on the nucleotide frequencies of the reads, that mitigates the impact of the bias.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...